Call us:
+91-8096410032
e-mail:
asociacionayuda.aaen@gmail.com
Home
JNRP
Current Issue
Archive
Blog
Images
Videos
Neurotrauma Registry
Neurotrauma Registry
Neurooncology Registry
PyBioStat
PyBioStat
NeuroExam
Tools
Resources
PDF Processor
Statistics
Colours
FAQ
About Us
Partners
Events
Testimonials
Feedback
Members
Contact
Login
Join Us
Home
JNRP
Current Issue
Archive
Blog
Images
Videos
Neurotrauma Registry
Neurotrauma Registry
Neurooncology Registry
PyBioStat
PyBioStat
NeuroExam
Tools
Resources
PDF Processor
Statistics
Colours
FAQ
About Us
Partners
Events
Testimonials
Feedback
Members
Contact
Login
Home
Neurooncology Data Form
Neurooncology Data Form
Neurooncology Data Form
Neurooncology Data Form
Personnel Details
Clinical Presentation
Clinical Examination
Blood Investigations
Radiology
Surgical Management
Radiation Therapy
Chemotherapy
Histopathology
Neuropathological Diagnosis
Outcome at Discharge
Follow Up
Section A - Personnel Details
Unique ID:
Institute Name:
IP/OP Number:
First Name:
Last Name:
Age:
Gender:
---------
Male
Female
Address Street:
Address PIN Code:
Address State:
Address Country:
Contact Number:
Email:
Informant:
---------
Patient Himself
Bystander
Mode of Arrival:
---------
Self
Private Vehicle
Ambulance/108 staff
Police/Firefighters
Rescuers
Bystanders/Neighbours
Relatives
Others (Please specify)
Education:
---------
Profession or Honours
Graduate or Postgraduate
Intermediate or post high school diploma
High school certificate
Middle school certificate
Primary school certificate
Illiterate
Occupational Status:
---------
Legislators, senior officials, and managers
Professionals
Technicians and associate professionals
Clerks
Skilled workers and shop and market sales workers
Skilled agricultural and fishery workers
Craft and related trade workers
Plant and machine operators and assemblers
Elementary occupation
Unemployed
Income:
---------
>20,482
10,241-20,481
7681-10,240
5120-7680
3072-5119
1034-3071
<1033
Marital Status:
---------
Married
Never married
Divorced
Section-B Management: Clinical Presentation
Headache:
Seizures:
Nausea and Vomiting:
Visual Disturbances:
Hearing Loss:
Tinnitus:
Cognitive Changes:
Motor Symptoms:
Sensory Deficits:
Speech and Language:
Balance and Coordination:
Endocrine Dysfunction:
Fatigue and Weakness:
Behavioral Changes:
Dizziness or Vertigo:
Consciousness Disturbance:
Difficulty swallowing (dysphagia):
Facial numbness:
Facial weakness:
Involuntary movements or tremors:
Section C: Clinical Examination
Blood pressure:
Heart rate:
Respiratory rate:
Temperature:
Level of consciousness (alertness):
Orientation (time):
Orientation (place):
Orientation (person):
Short-term memory:
Long-term memory:
Language fluency:
Language comprehension:
Language repetition:
Vision (acuity):
Vision (fields):
Fundoscopy for papilledema:
Pupillary response:
Extraocular movements:
Facial symmetry and strength:
Hearing function:
Vestibular function:
Swallowing reflex:
Gag reflex:
Tongue movement:
Speech articulation:
Muscle bulk:
Muscle tone:
Muscle strength:
Deep tendon reflexes:
Pathological reflexes (e.g., Babinski sign):
Gait:
Posture:
Light touch sensation:
Pain sensation:
Temperature sensation:
Vibration sensation:
Proprioception (sense of position):
Finger-to-nose coordination:
Heel-to-shin coordination:
Rapid alternating movements:
Ataxic gait:
Tandem walking (coordination):
Bladder control:
Bowel control:
Papilledema (via fundoscopy):
Optic atrophy (via fundoscopy):
Retinal abnormalities (via fundoscopy):
Bulging fontanelle (in infants):
Galactorrhea:
Gynecomastia:
Acromegaly:
Assessment of mood:
Assessment of behavior:
Assessment of higher cognitive functions:
Section D: Investigations at Admission - Blood
Hemoglobin (gm/dL):
Total leucocyte count (/mm3):
Blood Sugar Random (mg/dL):
Blood Sugar Fasting (mg/dL):
Blood Sugar PP (mg/dL):
Platelets (/mm3):
Cerebrospinal fluid cytology:
Blood or cerebrospinal fluid test:
Section E: Radiology
Date of CT:
CT Contrast:
CT Findings:
Date of MRI:
Time of MRI:
MRI Contrast:
MRI details:
MRI Findings:
Date of PET:
Time of PET:
PET Contrast:
eFAST:
Chest X-ray:
Cervical spine X-ray:
Dorsal spine X-ray:
Lumbar spine X-ray:
Pelvis X-ray:
Long bone x-rays:
CT cervical spine:
CT chest:
CT abdomen:
CT pelvis:
MRI brain:
MRI Spine:
DSA:
Section-F Surgical Management
Treatment:
---------
No
Radiotherapy Only
Chemotherapy Only
Radiotherapy & Chemotherapy
Unknown
Mode of Therapy:
---------
Surgery
Surgery + RT
Surgery + CRT
Surgery + CTX
CRT
RT
CTX
Observation alone
Others
Initial Surgery:
---------
None
Decompressive craniectomy
Biopsy
1-50% resection
50-75% resection
75-95% resection
95-99% resection
100% total resection
Extended tumor resection
Others
Date of Surgery:
Type of Surgery:
---------
None
Free-hand burr hole biopsy
Frameless stereotactic burr hole biopsy
Craniotomy for biopsy
Craniotomy for resection
Laminectomy for resection
Other (specify)
Primary Site:
---------
Central Nervous System
Metastases to CNS
Unknown Primary
Not Determined
Other (specify)
Extent of Surgery:
---------
None
Biopsy
Subtotal Resection
Total Gross Resection
Fluorescence Guided Resection
Functional Mapping Surgery
Tumour Location:
---------
Brain
Cerebellum
Cerebral hemisphere
Choroid plexus
Cranial nerve
Meninges NOS
Pineal gland
Pituitary gland
Skull
Spinal cord NOS
Spinal nerve root
Spine
Operation Approach:
Intraoperative Assistive Technologies:
Extent of Tumour Resection:
Blood Loss Volume:
Secondary Operation:
Tumour Characteristics: Multiplicity:
---------
Single
Multiple
Dissemination
LMM
Others
Tumour Characteristics: Laterality:
---------
Right
Left
Across Both Sides
On Both Sides
Central Neuroaxis
Others
Tumour Characteristics: Tumor Location:
---------
Frontal lobe
Temporal lobe
Parietal lobe
Occipital lobe
Insular gyri
Gliomatosis cerebri
Cerebellum
Midbrain
Pons
Medulla oblongata
Lateral ventricle
Third ventricle
Cerebral aqueduct
Fourth ventricle
Basal ganglia
Thalamus
Hypothalamus
Corpus callosum
Pineal region
Intraorbital
Pituitary gland
Optic nerve
Cerebello-pontine angle
Clivus
Cavernous sinus
Cranial nerve
Other skull base
Skull bone
LMM
Others
CSF Drainage:
Complication During the Whole Treatment:
---------
None
Intracranial hemorrhage
Cerebral infarction
Pneumonia
Pulmonary embolization
Deep vein thrombosis
Bone fracture
Second cancer
Others
Unknown
Pattern of Recurrence at Investigation:
---------
No recurrence
Local recurrence
New lesions
Unknown
Any Drug Therapy During the Whole Treatment:
---------
TMZ
ACNU
Other alkylating agents
Platinum drug
Vincristine
IFN
Etoposide
Ifosfamide
MTX
Molecular target drug
Hormone therapy
Steroid
Anticonvulsants
Dopamine agonist
Avastin
Gliadel
5-ALA
Talaporfin
Others
Any Therapy During the Whole Treatment:
---------
None
Surgery
WBRT
LBRT
SRS/SRT
Particle beam therapy
CTX
Molecular targeting drug
Dopamine agonist
Virus therapy
Vaccine therapy
Immunotherapy
Activated lymphocyte
Steroid
Anticonvulsants
Others
Section-G Management: Radiation Therapy
Start Date:
End Date:
Dose:
---------
45
54
60
Other (specify)
Fractions:
---------
5
15
20
30
Other (specify)
Fields:
---------
2
3
Other (specify)
Stereotactic Radiosurgery:
---------
Yes
No
Unknown
Completed:
---------
Yes
No
Unknown
If not completed, Due To:
---------
Toxicity
Patient Request
Disease Progression
Other Medical Problems
Death
Unknown
Section-H Management: Chemotherapy
Concurrent Chemotherapy + RT:
---------
Yes
No
Unknown
Start Date:
End Date:
Drugs Used:
---------
Temozolomide
BCNU
Carboplatin
PCV
CCNU
Procarbazine
Bevacizumab
Cisplatin
Vincristine
Etoposide
Cyclophosphamide
Other (specify)
Dose Reduction:
---------
Yes
No
Unknown
Completed:
---------
Yes
No
Unknown
If not completed, Due To:
---------
Toxicity
Patient Request
Disease Progression
Other Medical Problems
Death
Unknown
Toxicity:
---------
Hematologic
Nausea and Vomiting
Other (specify)
Section I Histopathology
WHO grade (according to WHO 2016 classification of CNS tumours):
Section J Neuropathological Diagnosis including Molecular and Genetic Markers
Pathology Report Date:
Site of Tumor:
Laterality of Tumor:
Histological Tumor Type:
Metastasis, Primary Site:
Tumor Size (L, W & H):
L:
W:
H:
Tumor Type:
WHO Tumor Grade:
---------
Grade I
Grade II
Grade III
Grade IV
Unavailable
Unknown
Not Applicable
Marker Testing Method: Test Type:
---------
Immunohistochemistry (IHC)
Fluorescent In Situ Hybridization (FISH)
Genotyping
DNA Sequencing
Polymerase Chain Reaction (PCR)
Unknown
Other (specify)
1p19q Analysis:
MGMT Methylation:
Ki-67 Analysis:
IDH1 Analysis:
p53 Analysis:
BRAF-KIAA1549 Analysis:
H3F3A K27 Analysis:
H3F3A G34 Analysis:
FGFR1 Analysis:
ATRX:
BRAF:
IDH1 Codon 132:
IDH2 Codon 172:
EGFR:
Section K Outcome at discharge
Outcome at discharge:
Outcome date:
Survival Status at discharge:
---------
Dead
Alive
Discharge Destination Hospital:
---------
Home
Rehabilitation
Higher treatment level
Another intermediate or low care somatic hospital ward
Others (Please specify)
Neurological Examination:
Endocrine Examination:
Postoperative Karnofsky Scale:
Postoperative ECOG Performance Status:
MRI:
CT:
Section L Follow Up
Date of Follow-Up:
Status:
---------
Alive
Deceased
Unknown
Lost to Follow-Up
Evidence of Recurrence:
---------
Yes
No
Unknown
Progression:
---------
Yes
No
Unknown
Stable Disease:
---------
Yes
No
Unknown
Patient Condition While Followed-Up:
Treatment After Discharge:
Symptoms and Physical Signs:
Follow-Up Imaging:
Save
Cancel